BDX 財務： Becton Dickinson and Co AI 分析



財務狀況

BDX 財務

Becton Dickinson and Co

$149.52

-0.46%

$-0.69

收盤價：Apr 28, 16:00:00 GMT-4

$149.52

盤前：Apr 29, 06:18:15 GMT-4

概觀預測收益股利財務狀況

關鍵數據

前收市價

$150.22

開盤價

$151.02

當日範圍

$147.85 - $151.85

52週區間

$127.58 - $187.35

交易量

2.0M

平均成交量

2.8M

股息收益率

2.70%

每股盈餘 (TTM)

6.12

市值

$42.5B

什麼是 BDX？

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.

功能特性

Markets

News

使用條款隱私權政策

收入

資產負債表

現金流量

年度

每季

BDX 收入

財務數據以百萬美元計。會計年度為二月至一月。

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
營收	21,924	5,252	5,891	5,509	5,272	5,168
營收年增率 (YoY)	6%	2%	8%	10%	5%	10%
營收成本	11,747	2,841	3,092	2,875	2,939	2,933
毛利	10,177	2,411	2,799	2,634	2,333	2,235
銷售、一般及管理費用	5,352	1,393	1,366	1,320	1,273	1,318
研發	1,227	306	322	297	302	343
營業費用	6,593	1,710	1,684	1,620	1,579	1,690
其他非營業收入 (費用)	-102	-10	-23	-32	-37	-15
稅前淨利	1,969	393	510	703	363	306
所得稅費用	212	11	17	129	55	3
淨利	1,757	382	493	574	308	303
淨利成長	1%	26%	17%	18%	-43%	8%
稀釋後流通股數	285.84	285.84	287.95	287.22	287.73	290.38
股數年變動 (YoY)	-2%	-2%	-1%	-1%	-1%	0%
每股盈餘 (稀釋)	6.14	1.33	1.71	1.99	1.07	1.04
每股盈餘成長率	2%	28%	18%	19%	-42%	9%
自由現金流	2,631	549	1,002	1,045	35	588
每股自由現金流	--	--	--	--	--	--
毛利率	46.41%	45.9%	47.51%	47.81%	44.25%	43.24%
營業利益率	16.34%	13.34%	18.92%	18.4%	14.3%	10.54%
淨利率	8.01%	7.27%	8.36%	10.41%	5.84%	5.86%
自由現金流利潤率	12%	10.45%	17%	18.96%	0.66%	11.37%
EBITDA	6,053	1,315	1,744	1,632	1,362	1,152
EBITDA 利潤率	27.6%	25.03%	29.6%	29.62%	25.83%	22.29%
EBITDA 中的折舊與攤銷	2,469	614	629	618	608	607
EBIT	3,584	701	1,115	1,014	754	545
EBIT 利潤率	16.34%	13.34%	18.92%	18.4%	14.3%	10.54%
有效稅率	10.76%	2.79%	3.33%	18.34%	15.15%	0.98%

Follow-Up Questions

Becton Dickinson and Co 的關鍵財務報表是什麼？



根據最新的財務報表（Form-10K），Becton Dickinson and Co 的總資產為 $0，淨損失為 $0

BDX 的關鍵財務比率是什麼？



Becton Dickinson and Co 的流動比率為 0，淨利潤率為 0，每股銷售為 $0。

Becton Dickinson and Co 的收入按細分市場或地理位置如何劃分？



Becton Dickinson and Co 最大收入來源為 Medication Delivery Solutions，在最近的收益報告中收入為 4,575,000,000。就地區而言，United States 是 Becton Dickinson and Co 的主要市場，收入為 12,790,000,000。

Becton Dickinson and Co 是否盈利？



無，根據最新的財務報表，Becton Dickinson and Co 的淨損失為 $0

Becton Dickinson and Co 有負債嗎？



無，Becton Dickinson and Co 的負債為 0

Becton Dickinson and Co 的流通股有多少？



Becton Dickinson and Co 的總流通股為 0

Becton Dickinson and Co (BDX) 財務

BDX 股價走勢圖